Abstract

Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers

Author(s): Zur Eyal

Issue: Nov/Dec 2011 - Volume 15, Number 6

Page(s): 458-463

Download in electronic PDF format for $75
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 1
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 2
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 3
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 4
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 5
  • Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Page 6

Abstract

Part 2 of a 2-part article about infantile hemangiomas, the most common benign tumors of infancy, was published previously in the International Journal of Pharmaceutical Compounding. Part 1 provided a comprehensive discussion about infantile hemangiomas, the current accumulative knowledge in the treatment of this pathology, and the use of oral propranolol in the treatment of infantile hemangiomas. This article continues that discussion but focuses on the topical treatment of this pathology.

Related Keywords

  • formulations
  • infantile hemangioma
  • infants
  • steroids
  • corticosteroids
  • immune response modifiers
  • beta blockers
  • topical preparations
  • literature review
  • iontophoresis
  • propranolol hydrochloride
  • skin permeability
  • percutaneous absorption

Related Categories

  • CANCER AND AIDS
  • DERMATOLOGY
  • FORMULATIONS
  • PEDIATRICS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
Jul/Aug 2017
Pg. 282-289
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Author(s): Choo Winnie
Sep/Oct 2011
Pg. 358-366
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Author(s): Zur Eyal
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Mar/Apr 2024
Pg. 129
Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality
Author(s):
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Nov/Dec 2012
Pg. 462-469
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Author(s): Zur Eyal
Jul/Aug 2014
Pg. 330
Propranolol Hydrochloride 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 325
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 513
Propranolol Hydrochloride Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 288-292
Basics of Compounding for Iontophoresis, Part II
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 513-515
Stability of Propranolol Hydrochloride in SyrSpend SF
Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 2006
Pg. 304
Propranolol Hydrochloride 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2007
Pg. 520-524
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2020
Pg. 482-490
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U